This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 October 2024 and includes updates on measles, mpox, avian influenza, West Nile virus, dengue, Marburg virus disease, a new strain of multidrug-resistant Shigella Sonnei ST152, and an overview of respiratory virus epidemiology in the EU/EEA.
This focused after-action review (AAR) investigated the use of evidence in the Finnish advice-making process for school interventions from December 2021 to January 2022, when the SARS-CoV-2 Omicron variant was circulating and schools remained open.
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in Rwanda for the European Union/European Economic Area (EU/EEA).
Join the ECDC Crowd and work on improving and transforming health science one task at a time with your insights on study design, statistical analysis, data collection and interpretation
About ECDC
ECDC collects, analyses and shares data on more than 50 infectious disease topics. ECDC experts assess risks to Europe and provide guidance to help countries prevent and respond to outbreaks and public health threats.